Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Standard Biotools Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 69 | 1 | 66 | −2 |
| Shares | 46.1M | 145 | 46.2M | +59.9K (+0.1%) |
| Value | $89.9M | $283 | $89.1M | −$823.7K (−0.9%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Standard Biotools Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 2,101,690 | $4.06M | 0.01% |
| Casdin Capital, LLC | 1,200,000 | $2.32M | 0.20% |
| Mirador Capital Partners LP | 47,956 | $92.6K | 0.02% |
| Occudo Quantitative Strategies LP | 32,954 | $63.6K | 0.01% |
| EverSource Wealth Advisors, LLC | 27,800 | $53.7K | 0.01% |
| Algert Global LLC | 26,090 | $50.4K | 0.00% |
| Walleye Capital LLC | 20,535 | $39.6K | 0.00% |
| Marshall Wace, LLP | 16,172 | $31.2K | 0.00% |
| HRT Financial LP | 11,877 | $22.0K | 0.00% |
| Group One Trading, L.P. | 9,720 | $18.8K | 0.00% |
| First Horizon Advisors, Inc. | 3,000 | $5.79K | 0.00% |
| Rhumbline Advisers | 2,891 | $5.58K | 0.00% |
| CWM, LLC | 81 | $0 | 0.00% |
Sold out (15)
Institutions that held Standard Biotools Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 31,647 | $61.7K |
| Barclays PLC | 27,385 | $53.4K |
| Lighthouse Investment Partners, LLC | 14,609 | $28.5K |
| Levin Capital Strategies, L.P. | 13,672 | $26.7K |
| Nwam LLC | 11,358 | $22.1K |
| Squarepoint Ops LLC | 11,138 | $21.7K |
| Two Sigma Securities, LLC | 11,014 | $21.5K |
| Qube Research & Technologies Ltd | 10,968 | $21.4K |
| XTX Topco Ltd | 10,744 | $21.0K |
| Point72 Middle East FZE | 9,314 | $18.2K |
| CarsonAllaria Wealth Management, Ltd. | 4,015 | $7.83K |
| Bellwether Advisors, LLC | 2,016 | $3.93K |
| Belpointe Asset Management LLC | 2,000 | $3.90K |
| Advisory Services Network, LLC | 500 | $975 |
| GWM Advisors LLC | 169 | $330 |
Not filed for Q2 2023 yet (1)
Institutions that held Standard Biotools Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Harvest Group Wealth Management, LLC | 145 | $283 |